Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
Author(s) -
Lameh Fananapazir,
Anthony Chang,
Stephen E. Epstein,
Dorothea McAreavey
Publication year - 1992
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.86.3.730
Subject(s) - medicine , cardiology , presyncope , hypertrophic cardiomyopathy , palpitations , sudden cardiac death , ventricular tachycardia , holter monitor , sudden death , implantable cardioverter defibrillator , electrocardiography , heart rate , blood pressure
Patients with hypertrophic cardiomyopathy (HCM) frequently have arrhythmias and hemodynamic abnormalities and are prone to sudden death and syncope. An important need exists for improved risk stratification and definition of appropriate investigation and therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom